Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG (NOVN)

132
End-of-day quote. End-of-day quote Swiss Exchange - 04/17
74.7 CHF   +0.47%
3h ago DR REDDY LABORATORIES : Drl in legal tangle over novartis gleevec drug
4h ago AstraZeneca cancer pipeline seen as draw for Pfizer
1d ago Pfizer considers $100 billion bid for AstraZeneca
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Latest news on NOVARTIS AG
03/27 NOVARTIS : Transgene Reports Fiscal Year 2013 Results and Provides Business Upda..
03/27 NOVARTIS : FDA Staff Says Novartis' Serelaxin Shouldn't Be Approved
03/27 NOVARTIS : Patent Issued for Method of Separating Excess Lens Forming Material f..
03/26 NOVARTIS : Patent Issued for Pyrimidylaminobenzamide Derivatives for Systemic Ma..
03/26 NOVARTIS : "Process for Manufacturing an Ophthalmic Lens" in Patent Application ..
03/26 NOVARTIS : Investigators from Novartis Institute for Biomedical Research Target ..
03/26 NOVARTIS : study published in NEJM showed LDK378 demonstrated an overall respons..
03/26 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
03/26 EXCLUSIVE - BAXTER EXPLORES SALE OF : sources
03/26DJEUROPE MARKETS : Europe Stocks Higher As ECB Stokes Stimulus Hopes
03/26 NOVARTIS : Patent Issued for Substituted Amino Bisphenyl Pentanoic Acid Derivati..
03/26 NOVARTIS : announces start of new secukinumab versus Stelara phase IIIb head-to-..
03/26 NOVARTIS : UK recommends Novartis Bexsero vaccine for inclusion in National Immu..
03/26 NOVARTIS : New phase III psoriasis data show rapid, significant skin clearance a..
03/25 NOVARTIS : Reports FDA Approval of Xolair for Chronic Idiopathic Urticaria
03/24 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
03/24 NOVARTIS : Alcon Research Assigned Patent
03/22 PDL BioPharma Updates on First Quarter 2014 Revenue Guidance of $133M
03/22 NOVARTIS : Meningitis B vaccine to be given to babies on the NHS
03/22 NOVARTIS : Meningitis B vaccine hope for infants after jab U-turn
03/22DJNOVARTIS : Chairman Stresses Need for R&D Investment
03/22 NOVARTIS : UK likely to introduce meningitis B vaccination soon
03/22 NOVARTIS : Vaccine U-turn welcomed by MP
03/22 NOVARTIS : New phase III psoriasis data show rapid, significant skin clearance a..
03/21 NOVARTIS : announces US FDA approval of Xolair® for chronic idiopathic urticaria..
03/21 NOVARTIS : announces US FDA approval of Xolair® for chronic idiopathic urticaria..
03/21DJGlaxo Wins Battle Over Asthma Drug
03/21 NOVARTIS : UK recommends Novartis Bexsero® vaccine for inclusion in National Imm..
03/21 NOVARTIS : announces start of new secukinumab (AIN457) versus Stelara® (ustekinu..
03/21 NOVARTIS : announces start of new secukinumab (AIN457) versus Stelara® (ustekinu..
03/20 NOVARTIS : introduces Lucentis® in state of the art pre-filled syringe »
03/19 NOVARTIS : "2'-Branched Nucleosides for Treatment of Viral Infections" in Patent..
03/19 NOVARTIS : Researchers Submit Patent Application, "Intraocular Lens Surgical Sys..
03/19 ANACOR PHARMACEUTICALS : Announces Appointment of Vince Ippolito as Chief Commer..
03/19 NOVARTIS : Patent Issued for Pharmaceutical Formulation Comprising a Water-Insol..
03/19 NOVARTIS : reports data at EBCC-9 for secondary survival endpoint of Afinitor tr..
03/19 NOVARTIS : reports data at EBCC-9 for secondary survival endpoint of Afinitor tr..
03/18 NOVARTIS : Roche, Novartis distance selves from SwissCham statement
03/17 NOVARTIS : Punjab CML Project ready to go
03/17 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
03/17 Formycon Appoints Top US Pharmaceuticals Manager Bernhard Hampl to the Adviso..
03/17 NOVARTIS : HSBC taps Symonds as European retail chief
03/17 NOVARTIS : Alcon Research Assigned Patent
03/17 NOVARTIS : Bexsero meningitis B vaccine receives clinical recommendation for use..
03/15 HSBC : Chairman ; companies today
03/14DJADR Shares End Lower; GlaxoSmithKline Shares Active
03/14 NOVARTIS AG : Italian prosecutors open probe against Roche, Novartis
03/14DJHSBC HOLDINGS PLC : HSBC Taps Symonds as Chairman of European Retail Unit
03/14DJHSBC HOLDINGS PLC : HSBC Appoints Former Novartis CFO as Chairman of European Re..
03/14 NOVARTIS AG : Italy prosecutors open probe against Roche, Novartis executives
03/14 NOVARTIS : Cabinet approves measures against pharmaceutical cartels
03/13 PDL BioPharma Reports First Quarter 2014 Revenue Guidance of $133M
03/13 Auto industry files 18 percent more international patents in 2013
03/13 NOVARTIS AG : Novartis Bexsero® meningitis B vaccine receives clinical recommend..
03/12 ANACOR PHARMACEUTICALS : Appoints Vince Ippolito as Chief Commercial Officer
03/12 PDL BioPharma Provides First Quarter 2014 Revenue Guidance of $133 Million
03/10 NOVARTIS AG : Health and Human Services Department (HHS); Food and Drug Administ..
03/10 NOVARTIS AG : Alcon Research Assigned Patent
03/10 NOVARTIS AG : Novartis announces positive Phase III study for Jakavi in patients..
03/07 SUPPLY OF TAB. CEFIXIME-200 MG.MFG : - Zuventas, Galpha, Pfizer, Cipla, Micro, S..
03/07 Supply Of Tab. Metroprolol Extended Release 50 mg
03/07 INDOCO REMEDIES LTD : Supply of Tab. Gliclazide-80 mg. plus Metformin HCL 500 mg..
03/07DJEUROPE MARKETS : European Stocks Head For Weekly Loss Ahead Of U.S. Data
03/07 NOVARTIS AG : Novartis announces Xolair approved in EU as first and only license..
03/07 NOVARTIS AG : Novartis announces positive Phase III study for Jakavi in patients..
03/07 NOVARTIS AG : Novartis Drug PrJakavi® Associated with Significant Clinical Benef..
03/07DJEUROPE MARKETS : European Stocks Head For Weekly Loss Ahead Of U.S. Data
03/07 NOVARTIS AG : Novartis announces positive Phase III study for Jakavi® in patient..
03/06 NOVARTIS AG : Italy prosecutors suspect Roche, Novartis of fraud - sources
03/06 NOVARTIS AG : Italy prosecutors suspect market manipulation, fraud in Roche, Nov..
03/06 NOVARTIS AG : Alcon Research Assigned Patent
03/06 NOVARTIS AG : Novartis announces Xolair® approved in EU as first and only licens..
03/05 NOVARTIS AG : Italy fines Swiss pharmaceutical giants for 'illicit deal'
03/05 IPSEN : Releases 2013 Results and 2014 Financial Objectives
03/05 FOUNDATION MEDICINE INC : Foundation Medicine Releases 4Q and Full Year 2013 Res..
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Income Statement Evolution
Novartis AG : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF